NCT05004818

Brief Summary

subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
Last Updated

August 13, 2021

Status Verified

August 1, 2021

Enrollment Period

1.4 years

First QC Date

August 11, 2021

Last Update Submit

August 11, 2021

Conditions

Keywords

Motion SicknessSeasicknessGalvanic vestibular stimulationRotatory chairVestibular time constant

Outcome Measures

Primary Outcomes (4)

  • Vestibular time constant

    Vestibular time constant was measured using repeated rotatory chair stimulation in step protocol.

    Until one month following the intervention

  • Seasickness severity

    Seasickness severity as determined by Wiker questionnaire at set time frames following the intervention

    Until one month following the intervention

  • scopolamine drug prescription

    scopolamine drug prescriptions were calculated for each participant and compared between the two groups

    Until three months following the intervention

  • Anti-motion sickness clinic visits

    Anti-motion sickness clinic visits were calculated for each participant and compared between the two groups

    Until three months following the intervention

Study Arms (2)

sham procedure

SHAM COMPARATOR

Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.

Procedure: Sham procedure

GVS stimulation coupled with inverse phase rotatory chair stimulation

EXPERIMENTAL

Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. The rotatory chair was activated in sinusoidal harmonic acceleration protocol in inverse phase to galvanic vestibular stimulation.

Procedure: GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol

Interventions

GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol

GVS stimulation coupled with inverse phase rotatory chair stimulation

Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.

sham procedure

Eligibility Criteria

Age19 Years - 44 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • maximum score of 7 on the Wiker seasickness questionnaire in moderate sea conditions, with wave height of 0 - 1.5 m
  • All had been sailing regularly for at least six months before enrolling in the study

You may not qualify if:

  • history of hearing loss
  • otoscopic findings of ear pathology
  • an implanted electrode
  • a finding of vestibulopathy on otoneurologic examination
  • withdrawal by any subject of his informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gutkovich YE, Lagami D, Jamison A, Fonar Y, Tal D. Galvanic vestibular stimulation as a novel treatment for seasickness. Exp Brain Res. 2022 Feb;240(2):429-437. doi: 10.1007/s00221-021-06263-w. Epub 2021 Nov 15.

MeSH Terms

Conditions

Motion SicknessSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsChemically-Induced DisordersMental Disorders

Study Officials

  • Dror Tal, PhD

    The Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2021

First Posted

August 13, 2021

Study Start

August 1, 2016

Primary Completion

January 1, 2018

Study Completion

July 1, 2019

Last Updated

August 13, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share